Total Payments
$4,050
2024 Payments
$1,085
Companies
17
Transactions
83
Medicare Patients
2,602
Medicare Billing
$3.3M
Payment Breakdown by Category
Food & Beverage$3,106 (76.7%)
Education$500.00 (12.3%)
Travel$443.26 (10.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,106 | 81 | 76.7% |
| Education | $500.00 | 1 | 12.3% |
| Travel and Lodging | $443.26 | 1 | 10.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Carl Zeiss Meditec USA, Inc. | $1,094 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $759.66 | 20 | $0 (2024) |
| Novocure Inc. | $371.91 | 8 | $0 (2023) |
| Medtronic, Inc. | $262.30 | 6 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $239.03 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $235.73 | 14 | $0 (2024) |
| iRhythm Technologies, Inc. | $227.39 | 1 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $151.62 | 2 | $0 (2024) |
| Zap Surgical Systems, Inc. | $150.29 | 1 | $0 (2021) |
| Eisai Inc. | $149.24 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,085 | 33 | AstraZeneca Pharmaceuticals LP ($343.87) |
| 2023 | $1,786 | 21 | Carl Zeiss Meditec USA, Inc. ($943.26) |
| 2022 | $747.94 | 16 | AstraZeneca Pharmaceuticals LP ($157.70) |
| 2021 | $379.32 | 10 | Zap Surgical Systems, Inc. ($150.29) |
| 2020 | $51.81 | 3 | Novartis Pharmaceuticals Corporation ($19.62) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $28.26 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: Oncology | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Oncology | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $7.02 | General |
| Category: Oncology | ||||||
| 08/26/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: Oncology | ||||||
| 08/21/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Oncology | ||||||
| 08/05/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $33.78 | General |
| Category: Oncology | ||||||
| 08/01/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Oncology | ||||||
| 07/30/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Oncology | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Oncology | ||||||
| 07/23/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: ONCOLOGY | ||||||
| 07/19/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: ONCOLOGY | ||||||
| 07/17/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Oncology | ||||||
| 06/17/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: ONCOLOGY | ||||||
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Oncology | ||||||
| 06/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Oncology | ||||||
| 06/04/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: ONCOLOGY | ||||||
| 05/16/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 04/16/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $115.56 | General |
| Category: Oncology | ||||||
| 03/23/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 781 | 12,777 | $10.7M | $2.2M |
| 2022 | 24 | 942 | 4,367 | $2.8M | $552,521 |
| 2021 | 21 | 828 | 3,979 | $2.7M | $567,426 |
| 2020 | 3 | 51 | 59 | $37,539 | $8,199 |
Total Patients
2,602
Total Services
21,182
Medicare Billing
$3.3M
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| A9607 | Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie | Office | 2023 | 13 | 9,100 | $8.2M | $1.7M | 20.8% |
| G6012 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | Office | 2023 | 27 | 463 | $403,097 | $86,468 | 21.5% |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 12 | 256 | $370,662 | $72,869 | 19.7% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 53 | 889 | $232,598 | $47,280 | 20.3% |
| G6014 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 20 mev or greater | Office | 2023 | 19 | 223 | $218,096 | $41,302 | 18.9% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 67 | 191 | $131,269 | $29,937 | 22.8% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 44 | 301 | $214,334 | $29,016 | 13.5% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Office | 2023 | 54 | 438 | $178,796 | $26,028 | 14.6% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 44 | 65 | $127,925 | $23,314 | 18.2% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 50 | 212 | $121,075 | $21,223 | 17.5% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 11 | 13 | $101,210 | $18,868 | 18.6% |
| 77295 | 3d radiation therapy planning | Office | 2023 | 27 | 37 | $77,983 | $14,238 | 18.3% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 51 | 187 | $59,468 | $13,129 | 22.1% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 40 | 50 | $54,911 | $10,694 | 19.5% |
| 79101 | Radioactive drug therapy through a vein | Office | 2023 | 21 | 65 | $26,390 | $7,568 | 28.7% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 48 | 53 | $68,813 | $6,590 | 9.6% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 12 | 16 | $28,663 | $5,978 | 20.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $19,809 | $4,438 | 22.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $18,000 | $3,649 | 20.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 23 | $8,849 | $2,384 | 26.9% |
| 77470 | Special radiation treatment | Office | 2023 | 16 | 17 | $12,810 | $1,918 | 15.0% |
| 77331 | Special radiation therapy planning | Office | 2023 | 19 | 33 | $7,804 | $1,727 | 22.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 31 | 35 | $5,049 | $1,561 | 30.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $4,565 | $1,382 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 18 | $4,681 | $1,317 | 28.1% |
About Dr. Daniel Mark, MD
Dr. Daniel Mark, MD is a Radiation Oncology healthcare provider based in West Palm Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/01/2015. The National Provider Identifier (NPI) number assigned to this provider is 1902291412.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Mark, MD has received a total of $4,050 in payments from pharmaceutical and medical device companies, with $1,085 received in 2024. These payments were reported across 83 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,106).
As a Medicare-enrolled provider, Mark has provided services to 2,602 Medicare beneficiaries, totaling 21,182 services with total Medicare billing of $3.3M. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Location West Palm Beach, FL
- Active Since 04/01/2015
- Last Updated 08/14/2022
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1902291412
Products in Payments
- INTRABEAM (Device) $943.26
- IMFINZI (Biological) $491.44
- Optune (Device) $256.67
- TAGRISSO (Drug) $246.54
- ZIO XT Patch (Device) $227.39
- OSTEOCOOL RF ABLATION SYSTEM (Device) $219.16
- KEYTRUDA (Biological) $197.26
- LUTATHERA (Drug) $192.20
- LIBTAYO (Biological) $151.62
- ZAP-X MV IMAGER (Device) $150.29
- INTRABEAM 600 (Device) $150.27
- Lenvima (Drug) $149.24
- PYLARIFY (Drug) $127.47
- JEVTANA (Drug) $108.01
- NovoTTF-100L (Device) $80.25
- Nubeqa (Drug) $48.79
- PLUVICTO (Drug) $46.83
- LYNPARZA (Biological) $38.47
- Magseed (Device) $32.80
- Flexitouch Plus (Device) $25.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Radiation Oncology Doctors in West Palm Beach
Dr. Georges Hobeika, M.d, M.D
Radiation Oncology — Payments: $1,590
Radiation Oncology $1,590
Silvio Garcia, Md, MD
Radiation Oncology — Payments: $476.51
Radiation Oncology $476.51
Dr. Anne Lewis, Md, MD
Radiation Oncology — Payments: $35.62
Radiation Oncology $35.62
Dr. Joseph Spaziani, M.d, M.D
Radiation Oncology
Radiation Oncology